{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "17",
                "@timestamp": "2023-05-17T08:07:35.000035-04:00",
                "@year": "2023",
                "@month": "05"
            },
            "ait:date-sort": {
                "@day": "27",
                "@year": "2021",
                "@month": "04"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {"xocs:funding-agency-matched-string": "Bara Scientific Co. Ltd."},
                {"xocs:funding-agency-matched-string": "Chukkapong Comsup"}
            ],
            "xocs:funding-addon-generated-timestamp": "2022-06-07T13:19:58.559Z",
            "xocs:funding-text": "The authors thank Chukkapong Comsup, Bara Scientific Co. Ltd., Assistant Product Manager of Analytical Product for providing the technical support and helpful discussion for this research. The authors\u2019 complement is also due to the demo version of the Shimadzu GCMS instrument and software kindly offered by Bara Scientific Co., Ltd, Thailand.",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "address-part": "Vibhavadi Rangsit Road",
                            "postal-code": "10900",
                            "@afid": "126193115",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Analytical Development"},
                                {"$": "Pharma Nueva Co."},
                                {"$": "Ltd."}
                            ],
                            "affiliation-id": {
                                "@afid": "126193115",
                                "@dptid": "126194627"
                            },
                            "@affiliation-instance-id": "2011938264-658ef40640ea271671f9a8e573094101",
                            "ce:source-text": "Department of Analytical Development, Pharma Nueva Co., Ltd., Vibhavadi Rangsit Road, Bangkok 10900, Thailand",
                            "@dptid": "126194627"
                        },
                        "author": [
                            {
                                "ce:given-name": "Wisut",
                                "preferred-name": {
                                    "ce:given-name": "Wisut",
                                    "ce:initials": "W.",
                                    "ce:surname": "Wichitnithad",
                                    "ce:indexed-name": "Wichitnithad W."
                                },
                                "@author-instance-id": "2011938264-91cb962785751afe7b2c6046be2e9c9f",
                                "@seq": "1",
                                "ce:initials": "W.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Wichitnithad",
                                "@auid": "9236903700",
                                "ce:indexed-name": "Wichitnithad W."
                            },
                            {
                                "ce:given-name": "Orawan",
                                "preferred-name": {
                                    "ce:given-name": "Orawan",
                                    "ce:initials": "O.",
                                    "ce:surname": "Sudtanon",
                                    "ce:indexed-name": "Sudtanon O."
                                },
                                "@author-instance-id": "2011938264-bf14dfa836a2a2107b4861daa690923b",
                                "@seq": "2",
                                "ce:initials": "O.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Sudtanon",
                                "@auid": "57218598387",
                                "ce:indexed-name": "Sudtanon O."
                            },
                            {
                                "ce:given-name": "Pawadee",
                                "preferred-name": {
                                    "ce:given-name": "Pawadee",
                                    "ce:initials": "P.",
                                    "ce:surname": "Srisunak",
                                    "ce:indexed-name": "Srisunak P."
                                },
                                "@author-instance-id": "2011938264-e161112add8b83c7953f2b14487b8b12",
                                "@seq": "3",
                                "ce:initials": "P.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Srisunak",
                                "@auid": "57223360278",
                                "ce:indexed-name": "Srisunak P."
                            },
                            {
                                "ce:given-name": "Kamonrak",
                                "preferred-name": {
                                    "ce:given-name": "Kamonrak",
                                    "ce:initials": "K.",
                                    "ce:surname": "Cheewatanakornkool",
                                    "ce:indexed-name": "Cheewatanakornkool K."
                                },
                                "@author-instance-id": "2011938264-73a73bd95c699e9ccdbc8eb7dd2e6f65",
                                "@seq": "4",
                                "ce:initials": "K.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Cheewatanakornkool",
                                "@auid": "23567587500",
                                "ce:indexed-name": "Cheewatanakornkool K."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "address-part": "Vibhavadi Rangsit Road",
                            "postal-code": "10900",
                            "@afid": "126193115",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Clinical Development"},
                                {"$": "Pharma Nueva Co."},
                                {"$": "Ltd."}
                            ],
                            "affiliation-id": {
                                "@afid": "126193115",
                                "@dptid": "126194628"
                            },
                            "@affiliation-instance-id": "2011938264-700a849601f5ecc465bdd70df513110e",
                            "ce:source-text": "Department of Clinical Development, Pharma Nueva Co., Ltd., Vibhavadi Rangsit Road, Bangkok 10900, Thailand",
                            "@dptid": "126194628"
                        },
                        "author": [
                            {
                                "ce:given-name": "Wisut",
                                "preferred-name": {
                                    "ce:given-name": "Wisut",
                                    "ce:initials": "W.",
                                    "ce:surname": "Wichitnithad",
                                    "ce:indexed-name": "Wichitnithad W."
                                },
                                "@author-instance-id": "2011938264-91cb962785751afe7b2c6046be2e9c9f",
                                "@seq": "1",
                                "ce:initials": "W.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Wichitnithad",
                                "@auid": "9236903700",
                                "ce:indexed-name": "Wichitnithad W."
                            },
                            {
                                "ce:given-name": "Siriwan",
                                "preferred-name": {
                                    "ce:given-name": "Siriwan",
                                    "ce:initials": "S.",
                                    "ce:surname": "Nantaphol",
                                    "ce:indexed-name": "Nantaphol S."
                                },
                                "@author-instance-id": "2011938264-d9c4a2f2708a8baf77cb963d0d939e97",
                                "@seq": "5",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Nantaphol",
                                "@auid": "56091887200",
                                "ce:indexed-name": "Nantaphol S."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "postal-code": "10330",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Food and Pharmaceutical Chemistry"},
                                {"$": "Faculty of Pharmaceutical Sciences"},
                                {"$": "Chulalongkorn University"},
                                {"$": "Phayathai"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "104425859"
                            },
                            "@affiliation-instance-id": "2011938264-040bea6ab31695aec875d1b7919d9b2f",
                            "ce:source-text": "Department of Food and Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Phayathai, Bangkok 10330, Thailand",
                            "@dptid": "104425859"
                        },
                        "author": [{
                            "ce:given-name": "Pornchai",
                            "preferred-name": {
                                "ce:given-name": "Pornchai",
                                "ce:initials": "P.",
                                "ce:surname": "Rojsitthisak",
                                "ce:indexed-name": "Rojsitthisak P."
                            },
                            "@author-instance-id": "2011938264-7a1fcbc02129d0e5dc0020dcaa506ac7",
                            "@seq": "6",
                            "ce:initials": "P.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Rojsitthisak",
                            "@auid": "23989729000",
                            "@orcid": "0000-0001-5991-1843",
                            "ce:indexed-name": "Rojsitthisak P."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "postal-code": "10330",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Natural Products for Ageing and Chronic Diseases Research Unit"},
                                {"$": "Chulalongkorn University"},
                                {"$": "Phayathai"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "119796848"
                            },
                            "@affiliation-instance-id": "2011938264-c838fee40f3722415f1cf20c42474b9a",
                            "ce:source-text": "Natural Products for Ageing and Chronic Diseases Research Unit, Chulalongkorn University, Phayathai, Bangkok 10330, Thailand",
                            "@dptid": "119796848"
                        },
                        "author": [{
                            "ce:given-name": "Pornchai",
                            "preferred-name": {
                                "ce:given-name": "Pornchai",
                                "ce:initials": "P.",
                                "ce:surname": "Rojsitthisak",
                                "ce:indexed-name": "Rojsitthisak P."
                            },
                            "@author-instance-id": "2011938264-7a1fcbc02129d0e5dc0020dcaa506ac7",
                            "@seq": "6",
                            "ce:initials": "P.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Rojsitthisak",
                            "@auid": "23989729000",
                            "@orcid": "0000-0001-5991-1843",
                            "ce:indexed-name": "Rojsitthisak P."
                        }]
                    }
                ],
                "citation-title": "Development of a Sensitive Headspace Gas Chromatography-Mass Spectrometry Method for the Simultaneous Determination of Nitrosamines in Losartan Active Pharmaceutical Ingredients",
                "abstracts": "© 2021 The Authors. Published by American Chemical Society.Nitrosamine impurities in angiotensin II receptor antagonists (sartans) containing a tetrazole group represent an urgent concern for active pharmaceutical ingredient (API) manufacturers and global regulators. Regarding safety, API manufacturers must develop methods to monitor the levels of each nitrosamine impurity before individual batch release. In this study, we developed and validated a sensitive, selective, and high-throughput method based on headspace gas chromatography-mass spectrometry (HS-GC-MS) for the simultaneous determination of four nitrosamines in losartan potassium API with simple sample preparation. N-Nitrosodimethylamine (NDMA, m/z 74), N-nitrosodiethylamine (NDEA, m/z 102), N-nitrosoethylisopropylamine (EIPNA, m/z 116), and N-nitrosodiisopropylamine (DIPNA, m/z 130) levels were quantified using an electron impact, single quadrupole mass spectrometer under a selected-ion-monitoring acquisition method. The method was validated according to the Q2(R1) ICH guidelines. The calibration curves of the assay ranged from 25 to 5000 ng/mL with limits of quantitation of 25 ppb for NDMA and NDEA and 50 ppb for DIPNA and EIPNA. The accuracy of the developed method ranged from -7.04% to 7.25%, and the precision %CV was ≤11.5. Other validation parameters, including specificity, stability, carryover, and robustness, met the validation criteria. In conclusion, the developed method was successfully applied for the determination of nitrosamines in losartan potassium APIs.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "postal-code": "10330",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Department of Food and Pharmaceutical Chemistry"},
                            {"$": "Faculty of Pharmaceutical Sciences"},
                            {"$": "Chulalongkorn University"},
                            {"$": "Phayathai"}
                        ],
                        "ce:source-text": "Department of Food and Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Phayathai, Bangkok 10330, Thailand"
                    },
                    "person": {
                        "ce:given-name": "Pornchai",
                        "ce:initials": "P.",
                        "ce:surname": "Rojsitthisak",
                        "ce:indexed-name": "Rojsitthisak P."
                    }
                },
                "citation-info": {
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "sourcetitle-abbrev": "ACS Omega",
                    "website": {"ce:e-address": {
                        "$": "pubs.acs.org/journal/acsodf",
                        "@type": "email"
                    }},
                    "@country": "usa",
                    "translated-sourcetitle": {"@xml:lang": "eng"},
                    "issn": {
                        "$": "24701343",
                        "@type": "electronic"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "6",
                            "@issue": "16"
                        },
                        "pagerange": {
                            "@first": "11048",
                            "@last": "11058"
                        }
                    },
                    "@type": "j",
                    "publicationyear": {"@first": "2021"},
                    "publisher": {"publishername": "American Chemical Society"},
                    "sourcetitle": "ACS Omega",
                    "@srcid": "21100828963",
                    "publicationdate": {
                        "month": "04",
                        "year": "2021",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "27 April 2021"
                        },
                        "day": "27"
                    }
                },
                "enhancement": {"classificationgroup": {"classifications": [
                    {
                        "@type": "ASJC",
                        "classification": [
                            {"$": "1600"},
                            {"$": "1500"}
                        ]
                    },
                    {
                        "@type": "SUBJABBR",
                        "classification": [
                            {"$": "CHEM"},
                            {"$": "CENG"}
                        ]
                    }
                ]}},
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "The authors thank Chukkapong Comsup, Bara Scientific Co. Ltd., Assistant Product Manager of Analytical Product for providing the technical support and helpful discussion for this research. The authors\u2019 complement is also due to the demo version of the Shimadzu GCMS instrument and software kindly offered by Bara Scientific Co., Ltd, Thailand.",
                        "@xml:lang": "eng"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2021 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "dbcollection": [
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "04",
                    "@timestamp": "BST 02:19:41",
                    "@year": "2021",
                    "@month": "06"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2011938264",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "933035091",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20211969379",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20211590410",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "20210013482832",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85105731098",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85105731098",
                            "@idtype": "SGR"
                        }
                    ],
                    "ce:doi": "10.1021/acsomega.1c00982"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "34",
                "reference": [
                    {
                        "ref-fulltext": "Barreras, A.; Gurk-Turner, C. Angiotensin II receptor blockers. Baylor Univ. Med. Cent. Proc. 2003, 16, 123-126, 10.1080/08998280.2003.11927893",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Angiotensin II receptor blockers"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1080/08998280.2003.11927893",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "33645959752",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {
                                    "@first": "123",
                                    "@last": "126"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Barreras",
                                    "ce:indexed-name": "Barreras A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Gurk-Turner",
                                    "ce:indexed-name": "Gurk-Turner C."
                                }
                            ]},
                            "ref-sourcetitle": "Baylor Univ. Med. Cent. Proc."
                        },
                        "ce:source-text": "Barreras, A.; Gurk-Turner, C. Angiotensin II receptor blockers. Baylor Univ. Med. Cent. Proc. 2003, 16, 123-126, 10.1080/08998280.2003.11927893"
                    },
                    {
                        "ref-fulltext": "Burnier, M.; Brunner, H. R. Angiotensin II receptor antagonists. Lancet 2000, 355, 637-645, 10.1016/S0140-6736(99)10365-9",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2000"},
                            "ref-title": {"ref-titletext": "Angiotensin II receptor antagonists"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S0140-6736(99)10365-9",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "0034685168",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "355"},
                                "pagerange": {
                                    "@first": "637",
                                    "@last": "645"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Burnier",
                                    "ce:indexed-name": "Burnier M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "H.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Brunner",
                                    "ce:indexed-name": "Brunner H.R."
                                }
                            ]},
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Burnier, M.; Brunner, H. R. Angiotensin II receptor antagonists. Lancet 2000, 355, 637-645, 10.1016/S0140-6736(99)10365-9"
                    },
                    {
                        "ref-fulltext": "Park, J.; Seo, J.; Lee, J.; Kwon, H. Distribution of seven N-nitrosamines in food. Toxicol. Res. 2015, 31, 279-288, 10.5487/TR.2015.31.3.279",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Distribution of seven N-nitrosamines in food"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.5487/TR.2015.31.3.279",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84947071952",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "31"},
                                "pagerange": {
                                    "@first": "279",
                                    "@last": "288"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Park",
                                    "ce:indexed-name": "Park J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Seo",
                                    "ce:indexed-name": "Seo J."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Lee",
                                    "ce:indexed-name": "Lee J."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Kwon",
                                    "ce:indexed-name": "Kwon H."
                                }
                            ]},
                            "ref-sourcetitle": "Toxicol. Res."
                        },
                        "ce:source-text": "Park, J.; Seo, J.; Lee, J.; Kwon, H. Distribution of seven N-nitrosamines in food. Toxicol. Res. 2015, 31, 279-288, 10.5487/TR.2015.31.3.279"
                    },
                    {
                        "ref-fulltext": "US FDA press announcements. FDA announces voluntary recall of several medicines containing valsartan following detection of an impurity. http:\\\\FDA.gov (accessed Jul 13, 2018)",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-website": {"ce:e-address": {
                                "$": "http:\\\\FDA.gov",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85055188098",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "US FDA press announcements. (accessed Jul 13)",
                            "ref-sourcetitle": "FDA Announces Voluntary Recall of Several Medicines Containing Valsartan following Detection of An Impurity"
                        },
                        "ce:source-text": "US FDA press announcements. FDA announces voluntary recall of several medicines containing valsartan following detection of an impurity. http:\\\\FDA.gov (accessed Jul 13, 2018)"
                    },
                    {
                        "ref-fulltext": "EMA release. CHMP list of questions. EMA/CHMP/467845/2018. https://www.ema.europa.eu/en/documents/referral/angiotensin-ii-receptor-antagonists-sartans-article-31-referral-chmp-list-questions-be-addressed-api_en.pdf (accessed Jul 16, 2018).",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.ema.europa.eu/en/documents/referral/angiotensin-ii-receptor-antagonists-sartans-article-31-referral-chmp-list-questions-be-addressed-api_en.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85106980101",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "EMA release. EMA/CHMP/467845/2018. (accessed Jul 16).",
                            "ref-sourcetitle": "CHMP List of Questions"
                        },
                        "ce:source-text": "EMA release. CHMP list of questions. EMA/CHMP/467845/2018. https://www.ema.europa.eu/en/documents/referral/angiotensin-ii-receptor-antagonists-sartans-article-31-referral-chmp-list-questions-be-addressed-api_en.pdf (accessed Jul 16, 2018)."
                    },
                    {
                        "ref-fulltext": "EMA release. Temporary interim limits for NMBA, DIPNA and EIPNA impurities in sartan blood pressure medicines. EMA/351053/2019 rev 1. https://www.ema.europa.eu/en/documents/other/temporary-interim-limits-nmba-dipna-eipna-impurities-sartan-blood-pressure-medicines_en.pdf (accessed Aug 20, 2019).",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.ema.europa.eu/en/documents/other/temporary-interim-limits-nmba-dipna-eipna-impurities-sartan-blood-pressure-medicines_en.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85084528378",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "EMA release. EMA/351053/2019 rev 1. (accessed Aug 20).",
                            "ref-sourcetitle": "Temporary Interim Limits for NMBA, DIPNA and EIPNA Impurities in Sartan Blood Pressure Medicines"
                        },
                        "ce:source-text": "EMA release. Temporary interim limits for NMBA, DIPNA and EIPNA impurities in sartan blood pressure medicines. EMA/351053/2019 rev 1. https://www.ema.europa.eu/en/documents/other/temporary-interim-limits-nmba-dipna-eipna-impurities-sartan-blood-pressure-medicines_en.pdf (accessed Aug 20, 2019)."
                    },
                    {
                        "ref-fulltext": "EMA release. Overview and recommendation: Lessons learnt from presence of N-nitrosamine impurities in sartan medicines. EMA/CHMP/526934/2019. https://www.ema.europa.eu/en/documents/report/lessons-learnt-presence-n-nitrosamine-impurities-sartan-medicines_en.pdf (accessed Jun 23, 2019).",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.ema.europa.eu/en/documents/report/lessons-learnt-presence-n-nitrosamine-impurities-sartan-medicines_en.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85107010554",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "EMA release. EMA/CHMP/526934/2019. (accessed Jun 23).",
                            "ref-sourcetitle": "Overview and Recommendation: Lessons Learnt from Presence of N-nitrosamine Impurities in Sartan Medicines"
                        },
                        "ce:source-text": "EMA release. Overview and recommendation: Lessons learnt from presence of N-nitrosamine impurities in sartan medicines. EMA/CHMP/526934/2019. https://www.ema.europa.eu/en/documents/report/lessons-learnt-presence-n-nitrosamine-impurities-sartan-medicines_en.pdf (accessed Jun 23, 2019)."
                    },
                    {
                        "ref-fulltext": "Oruganti, S. A viewpoint on the presence of N-nitrosodimethylamine (NDMA) impurity in certain generic samples of Valsartan, Drils Perspectives; Dr. Reddy's Institute of Life Sciences, 2018.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85060103089",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Dr. Reddy's Institute of Life Sciences.",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "ce:surname": "Oruganti",
                                "ce:indexed-name": "Oruganti S."
                            }]},
                            "ref-sourcetitle": "A Viewpoint on the Presence of N-nitrosodimethylamine (NDMA) Impurity in Certain Generic Samples of Valsartan, Drils Perspectives"
                        },
                        "ce:source-text": "Oruganti, S. A viewpoint on the presence of N-nitrosodimethylamine (NDMA) impurity in certain generic samples of Valsartan, Drils Perspectives; Dr. Reddy's Institute of Life Sciences, 2018."
                    },
                    {
                        "ref-fulltext": "EMA release. Assessment report. EMA/CHMP/217823/2019. https://www.ema.europa.eu/en/documents/variation-report/angiotensin-ii-receptor-antagonists-sartans-article-31-referral-chmp-assessment-report_en.pdf (accessed Feb 14, 2019).",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.ema.europa.eu/en/documents/variation-report/angiotensin-ii-receptor-antagonists-sartans-article-31-referral-chmp-assessment-report_en.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "84917000661",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "EMA release. EMA/CHMP/217823/2019. (accessed Feb 14).",
                            "ref-sourcetitle": "Assessment Report"
                        },
                        "ce:source-text": "EMA release. Assessment report. EMA/CHMP/217823/2019. https://www.ema.europa.eu/en/documents/variation-report/angiotensin-ii-receptor-antagonists-sartans-article-31-referral-chmp-assessment-report_en.pdf (accessed Feb 14, 2019)."
                    },
                    {
                        "ref-fulltext": "European network of OMCLs, OMCLs Release. Determination of NDMA in valsartan active substances and finished products by HPLC/UV; French National Agency for Medicines and Health Products Safety, 2018.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85107007891",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "European network of OMCLs, OMCLs Release. French National Agency for Medicines and Health Products Safety.",
                            "ref-sourcetitle": "Determination of NDMA in Valsartan Active Substances and Finished Products by HPLC/UV"
                        },
                        "ce:source-text": "European network of OMCLs, OMCLs Release. Determination of NDMA in valsartan active substances and finished products by HPLC/UV; French National Agency for Medicines and Health Products Safety, 2018."
                    },
                    {
                        "ref-fulltext": "European network of OMCLs, OMCLs Release. Test method for the determination of NDMA by LC/MS/MS in Valsartan finished products; Chemisches und Veterinäruntersuchungsamt: Karlsruhe, Germany, 2018.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85103723298",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "European network of OMCLs, OMCLs Release. Chemisches und Veterinäruntersuchungsamt: Karlsruhe, Germany.",
                            "ref-sourcetitle": "Test Method for the Determination of NDMA by LC/MS/MS in Valsartan Finished Products"
                        },
                        "ce:source-text": "European network of OMCLs, OMCLs Release. Test method for the determination of NDMA by LC/MS/MS in Valsartan finished products; Chemisches und Veterinäruntersuchungsamt: Karlsruhe, Germany, 2018."
                    },
                    {
                        "ref-fulltext": "European network of OMCLs, OMCLs Release. Determination of NDMA (HS-GC-MS) method 3/30, issue no. 1; Public Analyst's Laboratory: Galway, Ireland, 2018.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85106996934",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "European network of OMCLs, OMCLs Release. Public Analyst's Laboratory: Galway, Ireland.",
                            "ref-sourcetitle": "Determination of NDMA (HS-GC-MS) Method 3/30, Issue No. 1"
                        },
                        "ce:source-text": "European network of OMCLs, OMCLs Release. Determination of NDMA (HS-GC-MS) method 3/30, issue no. 1; Public Analyst's Laboratory: Galway, Ireland, 2018."
                    },
                    {
                        "ref-fulltext": "USFDA. GC/MS Headspace Method for NDMA in Valsartan Drug Substance and Drug Products; US Food and Drug Administration: Washington, DC, 2019.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85106981221",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "USFDA. US Food and Drug Administration: Washington, DC.",
                            "ref-sourcetitle": "GC/MS Headspace Method for NDMA in Valsartan Drug Substance and Drug Products"
                        },
                        "ce:source-text": "USFDA. GC/MS Headspace Method for NDMA in Valsartan Drug Substance and Drug Products; US Food and Drug Administration: Washington, DC, 2019."
                    },
                    {
                        "ref-fulltext": "USFDA. Combined N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA) Impurity Assay by GC/MS-Headspace; US Food and Drug Administration: Washington, DC, 2019.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85064557741",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "USFDA. US Food and Drug Administration: Washington, DC.",
                            "ref-sourcetitle": "Combined N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA) Impurity Assay by GC/MS-Headspace"
                        },
                        "ce:source-text": "USFDA. Combined N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA) Impurity Assay by GC/MS-Headspace; US Food and Drug Administration: Washington, DC, 2019."
                    },
                    {
                        "ref-fulltext": "Taiwan FDA. Method of Test for Nitrosamines in Medicines Multiple Analysis (GC-MS/MS Method); Taiwan Food and Drug Administration: Nangang, Taipei City, 2020.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85106978791",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Taiwan FDA. Taiwan Food and Drug Administration: Nangang, Taipei City.",
                            "ref-sourcetitle": "Method of Test for Nitrosamines in Medicines Multiple Analysis (GC-MS/MS Method)"
                        },
                        "ce:source-text": "Taiwan FDA. Method of Test for Nitrosamines in Medicines Multiple Analysis (GC-MS/MS Method); Taiwan Food and Drug Administration: Nangang, Taipei City, 2020."
                    },
                    {
                        "ref-fulltext": "Chang, S.; Chang, C.; Wang, L.; Chen, W.; Fan, S.; Zang, C.; Hsu, Y.; Lin, M.; Tseng, S.; Wang, D. A multi-analyte LC-MS/MS method for screening and quantification of nitrosamines in sartans. J. Food Drug Anal. 2020, 28, 98-107, 10.38212/2224-6614.1063",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "A multi-analyte LC-MS/MS method for screening and quantification of nitrosamines in sartans"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.38212/2224-6614.1063",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85102532516",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "28"},
                                "pagerange": {
                                    "@first": "98",
                                    "@last": "107"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Chang",
                                    "ce:indexed-name": "Chang S."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Chang",
                                    "ce:indexed-name": "Chang C."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang L."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Chen",
                                    "ce:indexed-name": "Chen W."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Fan",
                                    "ce:indexed-name": "Fan S."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Zang",
                                    "ce:indexed-name": "Zang C."
                                },
                                {
                                    "@seq": "7",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Hsu",
                                    "ce:indexed-name": "Hsu Y."
                                },
                                {
                                    "@seq": "8",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Lin",
                                    "ce:indexed-name": "Lin M."
                                },
                                {
                                    "@seq": "9",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Tseng",
                                    "ce:indexed-name": "Tseng S."
                                },
                                {
                                    "@seq": "10",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang D."
                                }
                            ]},
                            "ref-sourcetitle": "J. Food Drug Anal."
                        },
                        "ce:source-text": "Chang, S.; Chang, C.; Wang, L.; Chen, W.; Fan, S.; Zang, C.; Hsu, Y.; Lin, M.; Tseng, S.; Wang, D. A multi-analyte LC-MS/MS method for screening and quantification of nitrosamines in sartans. J. Food Drug Anal. 2020, 28, 98-107, 10.38212/2224-6614.1063"
                    },
                    {
                        "ref-fulltext": "USFDA. Combined Direct Injection N-Nitrosodimethylamine (NDMA), N-Nitrosodiethylamine (NDEA), N-Nitrosoethylisopropylamine (NEIPA), N-Nitrosodiisopropylamine (NDIPA), and N-Nitrosodibutylamine (NDBA) Impurity Assay by GC-MS/MS; US Food and Drug Administration: Washington, DC, 2019.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85092528622",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "USFDA. US Food and Drug Administration: Washington, DC.",
                            "ref-sourcetitle": "Combined Direct Injection N-Nitrosodimethylamine (NDMA), N-Nitrosodiethylamine (NDEA), N-Nitrosoethylisopropylamine (NEIPA), N-Nitrosodiisopropylamine (NDIPA), and N-Nitrosodibutylamine (NDBA) Impurity Assay by GC-MS/MS"
                        },
                        "ce:source-text": "USFDA. Combined Direct Injection N-Nitrosodimethylamine (NDMA), N-Nitrosodiethylamine (NDEA), N-Nitrosoethylisopropylamine (NEIPA), N-Nitrosodiisopropylamine (NDIPA), and N-Nitrosodibutylamine (NDBA) Impurity Assay by GC-MS/MS; US Food and Drug Administration: Washington, DC, 2019."
                    },
                    {
                        "ref-fulltext": "USFDA. Combined headspace N-Nitrosodimethylamine (NDMA), N-Nitrosodiethylamine (NDEA), N-Nitrosoethylisopropylamine (NEIPA), N-Nitrosodiisopropylamine (NDIPA), and N-Nitrosodibutylamine (NDBA) Impurity Assay by GC-MS/MS; US Food and Drug Administration: Washington, DC, 2019.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85092528622",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "USFDA. US Food and Drug Administration: Washington, DC.",
                            "ref-sourcetitle": "Combined Headspace N-Nitrosodimethylamine (NDMA), N-Nitrosodiethylamine (NDEA), N-Nitrosoethylisopropylamine (NEIPA), N-Nitrosodiisopropylamine (NDIPA), and N-Nitrosodibutylamine (NDBA) Impurity Assay by GC-MS/MS"
                        },
                        "ce:source-text": "USFDA. Combined headspace N-Nitrosodimethylamine (NDMA), N-Nitrosodiethylamine (NDEA), N-Nitrosoethylisopropylamine (NEIPA), N-Nitrosodiisopropylamine (NDIPA), and N-Nitrosodibutylamine (NDBA) Impurity Assay by GC-MS/MS; US Food and Drug Administration: Washington, DC, 2019."
                    },
                    {
                        "ref-fulltext": "Brian Byrd, J.; Chertow, G. M.; Bhalla, V. Hypertension hot potato-Anatomy of the angiotensin-receptor blocker recalls. N. Engl. J. Med. 2019, 380, 1589-1591, 10.1056/NEJMp1901657",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Hypertension hot potato - Anatomy of the angiotensin-receptor blocker recalls"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1056/NEJMp1901657",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85064977217",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "380"},
                                "pagerange": {
                                    "@first": "1589",
                                    "@last": "1591"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Brian Byrd",
                                    "ce:indexed-name": "Brian Byrd J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "G.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Chertow",
                                    "ce:indexed-name": "Chertow G.M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "V.",
                                    "@_fa": "true",
                                    "ce:surname": "Bhalla",
                                    "ce:indexed-name": "Bhalla V."
                                }
                            ]},
                            "ref-sourcetitle": "N. Engl. J. Med."
                        },
                        "ce:source-text": "Brian Byrd, J.; Chertow, G. M.; Bhalla, V. Hypertension hot potato-Anatomy of the angiotensin-receptor blocker recalls. N. Engl. J. Med. 2019, 380, 1589-1591, 10.1056/NEJMp1901657"
                    },
                    {
                        "ref-fulltext": "FDA Updates and Press Announcements on Angiotensin II Receptor Blocker (ARB) Recalls (Valsartan, Losartan, and Irbesartan): FDA updates table of interim limits for nitrosamine impurities in ARBS. https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-press-announcements-angiotensin-ii-receptor-blocker-arb-recalls-valsartan-losartan (accessed Feb 28, 2019).",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-press-announcements-angiotensin-ii-receptor-blocker-arb-recalls-valsartan-losartan",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85106974127",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "(accessed Feb 28).",
                            "ref-sourcetitle": "FDA Updates and Press Announcements on Angiotensin II Receptor Blocker (ARB) Recalls (Valsartan, Losartan, and Irbesartan): FDA Updates Table of Interim Limits for Nitrosamine Impurities in ARBS"
                        },
                        "ce:source-text": "FDA Updates and Press Announcements on Angiotensin II Receptor Blocker (ARB) Recalls (Valsartan, Losartan, and Irbesartan): FDA updates table of interim limits for nitrosamine impurities in ARBS. https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-press-announcements-angiotensin-ii-receptor-blocker-arb-recalls-valsartan-losartan (accessed Feb 28, 2019)."
                    },
                    {
                        "ref-fulltext": "EMA release. Questions and answers for marketing authorization holder/applicants on the CHMP Opinion for the Article 5 (3) of Regulation (EC) No 726/2004 referral on nitrosamine impurities in human medicinal products. EMA/CHMP/409815/2020. https://www.ema.europa.eu/en/documents/referral/nitrosamines-emea-h-a53-1490-questions-answers-marketing-authorisation-holders/applicants-chmp-opinion-article-53-regulation-ec-no-726/2004-referral-nitrosamine-impurities-human-medicinal-products_en.pdf (accessed Aug 03, 2020).",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.ema.europa.eu/en/documents/referral/nitrosamines-emea-h-a53-1490-questions-answers-marketing-authorisation-holders/applicants-chmp-opinion-article-53-regulation-ec-no-726/2004-referral-nitrosamine-impurities-human-medicinal-products_en.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85104360161",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "EMA release. EMA/CHMP/409815/2020. (accessed Aug 03).",
                            "ref-sourcetitle": "Questions and Answers for Marketing Authorization Holder/applicants on the CHMP Opinion for the Article 5 (3) of Regulation (EC) No 726/2004 Referral on Nitrosamine Impurities in Human Medicinal Products"
                        },
                        "ce:source-text": "EMA release. Questions and answers for marketing authorization holder/applicants on the CHMP Opinion for the Article 5 (3) of Regulation (EC) No 726/2004 referral on nitrosamine impurities in human medicinal products. EMA/CHMP/409815/2020. https://www.ema.europa.eu/en/documents/referral/nitrosamines-emea-h-a53-1490-questions-answers-marketing-authorisation-holders/applicants-chmp-opinion-article-53-regulation-ec-no-726/2004-referral-nitrosamine-impurities-human-medicinal-products_en.pdf (accessed Aug 03, 2020)."
                    },
                    {
                        "ref-fulltext": "EMA release. Assessment report: Procedure under Article 5(3)of Regulation EC (No) 726/2004 Nitrosamine impurities in human medicinal products. EMA/CHMP/369136/2020. https://www.ema.europa.eu/en/documents/referral/nitrosamines-emea-h-a53-1490-assessment-report_en.pdf (accessed June 25, 2020).",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.ema.europa.eu/en/documents/referral/nitrosamines-emea-h-a53-1490-assessment-report_en.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85107002987",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "EMA release. EMA/CHMP/369136/2020. (accessed June 25).",
                            "ref-sourcetitle": "Assessment Report: Procedure under Article 5(3)of Regulation EC (No) 726/2004 Nitrosamine Impurities in Human Medicinal Products."
                        },
                        "ce:source-text": "EMA release. Assessment report: Procedure under Article 5(3)of Regulation EC (No) 726/2004 Nitrosamine impurities in human medicinal products. EMA/CHMP/369136/2020. https://www.ema.europa.eu/en/documents/referral/nitrosamines-emea-h-a53-1490-assessment-report_en.pdf (accessed June 25, 2020)."
                    },
                    {
                        "ref-fulltext": "USFDA. Liquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS) Method for the Determination of Six Nitrosamine Impurities in ARB Drugs; US Food and Drug Administration: Washington, DC, 2019. https://www.fda.gov/media/125478/download",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.fda.gov/media/125478/download",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85088290749",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "USFDA. US Food and Drug Administration: Washington, DC.",
                            "ref-sourcetitle": "Liquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS) Method for the Determination of Six Nitrosamine Impurities in ARB Drugs"
                        },
                        "ce:source-text": "USFDA. Liquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS) Method for the Determination of Six Nitrosamine Impurities in ARB Drugs; US Food and Drug Administration: Washington, DC, 2019. https://www.fda.gov/media/125478/download"
                    },
                    {
                        "ref-fulltext": "Yang, J.; Andres Marzan, T.; Ye, W.; Sommers, C. D.; Rodriguez, J. D.; Keire, D. A. A cautionary tale: Quantitative LC-HRMS analytical procedures for the analysis of N-Nitrosodimethylamine in metformin. AAPS J. 2020, 20, 89 10.1208/s12248-020-00473-w",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "A cautionary tale: Quantitative LC-HRMS analytical procedures for the analysis of N-Nitrosodimethylamine in metformin"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1208/s12248-020-00473-w",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85087297136",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "20"},
                                "pagerange": {"@first": "89"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Yang",
                                    "ce:indexed-name": "Yang J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Andres Marzan",
                                    "ce:indexed-name": "Andres Marzan T."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Ye",
                                    "ce:indexed-name": "Ye W."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "C.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Sommers",
                                    "ce:indexed-name": "Sommers C.D."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "J.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Rodriguez",
                                    "ce:indexed-name": "Rodriguez J.D."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "D.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Keire",
                                    "ce:indexed-name": "Keire D.A."
                                }
                            ]},
                            "ref-sourcetitle": "AAPS J."
                        },
                        "ce:source-text": "Yang, J.; Andres Marzan, T.; Ye, W.; Sommers, C. D.; Rodriguez, J. D.; Keire, D. A. A cautionary tale: Quantitative LC-HRMS analytical procedures for the analysis of N-Nitrosodimethylamine in metformin. AAPS J. 2020, 20, 89 10.1208/s12248-020-00473-w"
                    },
                    {
                        "ref-fulltext": "Tsutsumi, T.; Akiyama, H.; Demizu, Y.; Uchiyama, N.; Masada, S.; Tsuji, G.; Arai, R.; Abe, Y.; Hakamatsuka, T.; Izutsu, K.; Goda, Y.; Okuda, H. Analysis of an impurity, N-Nitrosodimethylamine, in valsartan drug substances and associated products using GC-MS. Biol. Pharm. Bull. 2019, 42, 547-551, 10.1248/bpb.b19-00006",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Analysis of an impurity, N-Nitrosodimethylamine, in valsartan drug substances and associated products using GC-MS"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1248/bpb.b19-00006",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85063983072",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "42"},
                                "pagerange": {
                                    "@first": "547",
                                    "@last": "551"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Tsutsumi",
                                    "ce:indexed-name": "Tsutsumi T."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Akiyama",
                                    "ce:indexed-name": "Akiyama H."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Demizu",
                                    "ce:indexed-name": "Demizu Y."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Uchiyama",
                                    "ce:indexed-name": "Uchiyama N."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Masada",
                                    "ce:indexed-name": "Masada S."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Tsuji",
                                    "ce:indexed-name": "Tsuji G."
                                },
                                {
                                    "@seq": "7",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Arai",
                                    "ce:indexed-name": "Arai R."
                                },
                                {
                                    "@seq": "8",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Abe",
                                    "ce:indexed-name": "Abe Y."
                                },
                                {
                                    "@seq": "9",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Hakamatsuka",
                                    "ce:indexed-name": "Hakamatsuka T."
                                },
                                {
                                    "@seq": "10",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Izutsu",
                                    "ce:indexed-name": "Izutsu K."
                                },
                                {
                                    "@seq": "11",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Goda",
                                    "ce:indexed-name": "Goda Y."
                                },
                                {
                                    "@seq": "12",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Okuda",
                                    "ce:indexed-name": "Okuda H."
                                }
                            ]},
                            "ref-sourcetitle": "Biol. Pharm. Bull."
                        },
                        "ce:source-text": "Tsutsumi, T.; Akiyama, H.; Demizu, Y.; Uchiyama, N.; Masada, S.; Tsuji, G.; Arai, R.; Abe, Y.; Hakamatsuka, T.; Izutsu, K.; Goda, Y.; Okuda, H. Analysis of an impurity, N-Nitrosodimethylamine, in valsartan drug substances and associated products using GC-MS. Biol. Pharm. Bull. 2019, 42, 547-551, 10.1248/bpb.b19-00006"
                    },
                    {
                        "ref-fulltext": "ICH Harmonised tripartite guideline: Validation of Analytical Procedures: Text and methodology Q2(R1). Current Step 4 version (accessed Oct 27, 1994).",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1994"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85106974837",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "ICH Harmonised tripartite guideline: Validation of Analytical Procedures: Text and methodology Q2(R1). Current Step 4 version (accessed Oct 27)."
                        },
                        "ce:source-text": "ICH Harmonised tripartite guideline: Validation of Analytical Procedures: Text and methodology Q2(R1). Current Step 4 version (accessed Oct 27, 1994)."
                    },
                    {
                        "ref-fulltext": "Danzer, K.; Currie, L. A. Guidelines for calibration in analytical chemistry. Pure Appl. Chem. 1998, 70, 993-1014, 10.1351/pac199870040993",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1998"},
                            "ref-title": {"ref-titletext": "Guidelines for calibration in analytical chemistry"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1351/pac199870040993",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85025633001",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "70"},
                                "pagerange": {
                                    "@first": "993",
                                    "@last": "1014"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Danzer",
                                    "ce:indexed-name": "Danzer K."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Currie",
                                    "ce:indexed-name": "Currie L.A."
                                }
                            ]},
                            "ref-sourcetitle": "Pure Appl. Chem."
                        },
                        "ce:source-text": "Danzer, K.; Currie, L. A. Guidelines for calibration in analytical chemistry. Pure Appl. Chem. 1998, 70, 993-1014, 10.1351/pac199870040993"
                    },
                    {
                        "ref-fulltext": "Barwick, V. A. Preparation of Calibration Curves: A Guide to Best Practice. LGC/VAM/2003/032, 2003, 1-27.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84856224634",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {"pagerange": {
                                "@first": "1",
                                "@last": "27"
                            }},
                            "ref-text": "LGC/VAM/2003/032.",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "V.A.",
                                "@_fa": "true",
                                "ce:surname": "Barwick",
                                "ce:indexed-name": "Barwick V.A."
                            }]},
                            "ref-sourcetitle": "Preparation of Calibration Curves: A Guide to Best Practice"
                        },
                        "ce:source-text": "Barwick, V. A. Preparation of Calibration Curves: A Guide to Best Practice. LGC/VAM/2003/032, 2003, 1-27."
                    },
                    {
                        "ref-fulltext": "Crews, C. The determination of N-nitrosamines in food. Qual. Assur. Saf. Crops Foods 2010, 2, 2-12, 10.1111/j.1757-837X.2010.00049.x",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "The determination of N-nitrosamines in food"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/j.1757-837X.2010.00049.x",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84859830691",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "2"},
                                "pagerange": {
                                    "@first": "2",
                                    "@last": "12"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "ce:surname": "Crews",
                                "ce:indexed-name": "Crews C."
                            }]},
                            "ref-sourcetitle": "Qual. Assur. Saf. Crops Foods"
                        },
                        "ce:source-text": "Crews, C. The determination of N-nitrosamines in food. Qual. Assur. Saf. Crops Foods 2010, 2, 2-12, 10.1111/j.1757-837X.2010.00049.x"
                    },
                    {
                        "ref-fulltext": "Seyler, T. H.; Kim, J. G.; Hodgson, J. A.; Cowan, E. A.; Blount, B. C.; Wang, L. Quantitation of urinary volatile nitrosamines from exposure to tobacco smoke. J. Anal. Toxicol. 2013, 37, 195-202, 10.1093/jat/bkt020",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Quantitation of urinary volatile nitrosamines from exposure to tobacco smoke"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/jat/bkt020",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84876023236",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "37"},
                                "pagerange": {
                                    "@first": "195",
                                    "@last": "202"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "T.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Seyler",
                                    "ce:indexed-name": "Seyler T.H."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.G.",
                                    "@_fa": "true",
                                    "ce:surname": "Kim",
                                    "ce:indexed-name": "Kim J.G."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Hodgson",
                                    "ce:indexed-name": "Hodgson J.A."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "E.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Cowan",
                                    "ce:indexed-name": "Cowan E.A."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "B.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Blount",
                                    "ce:indexed-name": "Blount B.C."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang L."
                                }
                            ]},
                            "ref-sourcetitle": "J. Anal. Toxicol."
                        },
                        "ce:source-text": "Seyler, T. H.; Kim, J. G.; Hodgson, J. A.; Cowan, E. A.; Blount, B. C.; Wang, L. Quantitation of urinary volatile nitrosamines from exposure to tobacco smoke. J. Anal. Toxicol. 2013, 37, 195-202, 10.1093/jat/bkt020"
                    },
                    {
                        "ref-fulltext": "Munch, J. W.; Bassett, M. V. Method 521. Determination of Nitrosamines in Drinking Water by Solid-phase Extraction and Capillary Column Gas Chromatography with Large Volume Injection and Chemical Ionization Tandem Mass Spectrometry (MS/MS); U.S. Environmental Protection Agency: Cincinnati, Ohio, 2004.",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33845616221",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "U.S. Environmental Protection Agency: Cincinnati, Ohio.",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.W.",
                                    "@_fa": "true",
                                    "ce:surname": "Munch",
                                    "ce:indexed-name": "Munch J.W."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.V.",
                                    "@_fa": "true",
                                    "ce:surname": "Bassett",
                                    "ce:indexed-name": "Bassett M.V."
                                }
                            ]},
                            "ref-sourcetitle": "Method 521. Determination of Nitrosamines in Drinking Water by Solid-phase Extraction and Capillary Column Gas Chromatography with Large Volume Injection and Chemical Ionization Tandem Mass Spectrometry (MS/MS)"
                        },
                        "ce:source-text": "Munch, J. W.; Bassett, M. V. Method 521. Determination of Nitrosamines in Drinking Water by Solid-phase Extraction and Capillary Column Gas Chromatography with Large Volume Injection and Chemical Ionization Tandem Mass Spectrometry (MS/MS); U.S. Environmental Protection Agency: Cincinnati, Ohio, 2004."
                    },
                    {
                        "ref-fulltext": "Parr, M. K.; Joseph, J. F. NDMA impurity in valsartan and other pharmaceutical products: Analytical methods for the determination of N-nitrosamines. J. Pharm. Biomed. Anal. 2019, 164, 536-549, 10.1016/j.jpba.2018.11.010",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "NDMA impurity in valsartan and other pharmaceutical products: Analytical methods for the determination of N-nitrosamines"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.jpba.2018.11.010",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85056644545",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "164"},
                                "pagerange": {
                                    "@first": "536",
                                    "@last": "549"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Parr",
                                    "ce:indexed-name": "Parr M.K."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.F.",
                                    "@_fa": "true",
                                    "ce:surname": "Joseph",
                                    "ce:indexed-name": "Joseph J.F."
                                }
                            ]},
                            "ref-sourcetitle": "J. Pharm. Biomed. Anal."
                        },
                        "ce:source-text": "Parr, M. K.; Joseph, J. F. NDMA impurity in valsartan and other pharmaceutical products: Analytical methods for the determination of N-nitrosamines. J. Pharm. Biomed. Anal. 2019, 164, 536-549, 10.1016/j.jpba.2018.11.010"
                    },
                    {
                        "ref-fulltext": "Şerban, E. S.; Socaci, S. A.; Tofanǎ, M.; Maier, S. C.; Bojiţǎ, M. Advantages of \" headspace\" technique for GC/MS analysis of essential oils. Farmacia 2012, 60, 249-256",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Advantages of \" headspace\" technique for GC/MS analysis of essential oils"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84869006676",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "60"},
                                "pagerange": {
                                    "@first": "249",
                                    "@last": "256"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "E.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Şerban",
                                    "ce:indexed-name": "Serban E.S."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Socaci",
                                    "ce:indexed-name": "Socaci S.A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Tofanǎ",
                                    "ce:indexed-name": "Tofana M."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "S.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Maier",
                                    "ce:indexed-name": "Maier S.C."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Bojiţǎ",
                                    "ce:indexed-name": "Bojita M."
                                }
                            ]},
                            "ref-sourcetitle": "Farmacia"
                        },
                        "ce:source-text": "Şerban, E. S.; Socaci, S. A.; Tofanǎ, M.; Maier, S. C.; Bojiţǎ, M. Advantages of \" headspace\" technique for GC/MS analysis of essential oils. Farmacia 2012, 60, 249-256"
                    },
                    {
                        "ref-fulltext": "Ibrahim, M. M. Investigation on thermal stability and purity determination of two antihypertensive drugs, valsartan and losartan potassium. Int. J. Curr. Pharm. Res. 2015, 7, 64-69",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Investigation on thermal stability and purity determination of two antihypertensive drugs, valsartan and losartan potassium"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84995420782",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {
                                    "@first": "64",
                                    "@last": "69"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "M.M.",
                                "@_fa": "true",
                                "ce:surname": "Ibrahim",
                                "ce:indexed-name": "Ibrahim M.M."
                            }]},
                            "ref-sourcetitle": "Int. J. Curr. Pharm. Res."
                        },
                        "ce:source-text": "Ibrahim, M. M. Investigation on thermal stability and purity determination of two antihypertensive drugs, valsartan and losartan potassium. Int. J. Curr. Pharm. Res. 2015, 7, 64-69"
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "126193115",
            "affilname": "Ltd.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126193115",
            "affiliation-country": "Thailand"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85105731098",
        "dc:description": "Nitrosamine impurities in angiotensin II receptor antagonists (sartans) containing a tetrazole group represent an urgent concern for active pharmaceutical ingredient (API) manufacturers and global regulators. Regarding safety, API manufacturers must develop methods to monitor the levels of each nitrosamine impurity before individual batch release. In this study, we developed and validated a sensitive, selective, and high-throughput method based on headspace gas chromatography-mass spectrometry (HS-GC-MS) for the simultaneous determination of four nitrosamines in losartan potassium API with simple sample preparation. N-Nitrosodimethylamine (NDMA, m/z 74), N-nitrosodiethylamine (NDEA, m/z 102), N-nitrosoethylisopropylamine (EIPNA, m/z 116), and N-nitrosodiisopropylamine (DIPNA, m/z 130) levels were quantified using an electron impact, single quadrupole mass spectrometer under a selected-ion-monitoring acquisition method. The method was validated according to the Q2(R1) ICH guidelines. The calibration curves of the assay ranged from 25 to 5000 ng/mL with limits of quantitation of 25 ppb for NDMA and NDEA and 50 ppb for DIPNA and EIPNA. The accuracy of the developed method ranged from -7.04% to 7.25%, and the precision %CV was ≤11.5. Other validation parameters, including specificity, stability, carryover, and robustness, met the validation criteria. In conclusion, the developed method was successfully applied for the determination of nitrosamines in losartan potassium APIs.",
        "prism:coverDate": "2021-04-27",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85105731098",
        "dc:creator": {"author": [{
            "ce:given-name": "Wisut",
            "preferred-name": {
                "ce:given-name": "Wisut",
                "ce:initials": "W.",
                "ce:surname": "Wichitnithad",
                "ce:indexed-name": "Wichitnithad W."
            },
            "@seq": "1",
            "ce:initials": "W.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "126193115",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126193115"
                },
                {
                    "@id": "126193115",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126193115"
                }
            ],
            "ce:surname": "Wichitnithad",
            "@auid": "9236903700",
            "author-url": "https://api.elsevier.com/content/author/author_id/9236903700",
            "ce:indexed-name": "Wichitnithad W."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85105731098"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105731098&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85105731098&origin=inward"
            }
        ],
        "source-id": "21100828963",
        "citedby-count": "17",
        "prism:volume": "6",
        "subtype": "ar",
        "dc:title": "Development of a Sensitive Headspace Gas Chromatography-Mass Spectrometry Method for the Simultaneous Determination of Nitrosamines in Losartan Active Pharmaceutical Ingredients",
        "openaccess": "1",
        "prism:issn": "24701343",
        "publishercopyright": "© 2021 The Authors. Published by American Chemical Society.",
        "prism:issueIdentifier": "16",
        "subtypeDescription": "Article",
        "prism:publicationName": "ACS Omega",
        "prism:pageRange": "11048-11058",
        "prism:endingPage": "11058",
        "openaccessFlag": "true",
        "prism:doi": "10.1021/acsomega.1c00982",
        "prism:startingPage": "11048",
        "dc:identifier": "SCOPUS_ID:85105731098",
        "dc:publisher": "American Chemical Society"
    },
    "idxterms": null,
    "language": {"@xml:lang": "eng"},
    "authkeywords": null,
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Chemistry (all)",
            "@code": "1600",
            "@abbrev": "CHEM"
        },
        {
            "@_fa": "true",
            "$": "Chemical Engineering (all)",
            "@code": "1500",
            "@abbrev": "CENG"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Wisut",
            "preferred-name": {
                "ce:given-name": "Wisut",
                "ce:initials": "W.",
                "ce:surname": "Wichitnithad",
                "ce:indexed-name": "Wichitnithad W."
            },
            "@seq": "1",
            "ce:initials": "W.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "126193115",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126193115"
                },
                {
                    "@id": "126193115",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126193115"
                }
            ],
            "ce:surname": "Wichitnithad",
            "@auid": "9236903700",
            "author-url": "https://api.elsevier.com/content/author/author_id/9236903700",
            "ce:indexed-name": "Wichitnithad W."
        },
        {
            "ce:given-name": "Orawan",
            "preferred-name": {
                "ce:given-name": "Orawan",
                "ce:initials": "O.",
                "ce:surname": "Sudtanon",
                "ce:indexed-name": "Sudtanon O."
            },
            "@seq": "2",
            "ce:initials": "O.",
            "@_fa": "true",
            "affiliation": {
                "@id": "126193115",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126193115"
            },
            "ce:surname": "Sudtanon",
            "@auid": "57218598387",
            "author-url": "https://api.elsevier.com/content/author/author_id/57218598387",
            "ce:indexed-name": "Sudtanon O."
        },
        {
            "ce:given-name": "Pawadee",
            "preferred-name": {
                "ce:given-name": "Pawadee",
                "ce:initials": "P.",
                "ce:surname": "Srisunak",
                "ce:indexed-name": "Srisunak P."
            },
            "@seq": "3",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "126193115",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126193115"
            },
            "ce:surname": "Srisunak",
            "@auid": "57223360278",
            "author-url": "https://api.elsevier.com/content/author/author_id/57223360278",
            "ce:indexed-name": "Srisunak P."
        },
        {
            "ce:given-name": "Kamonrak",
            "preferred-name": {
                "ce:given-name": "Kamonrak",
                "ce:initials": "K.",
                "ce:surname": "Cheewatanakornkool",
                "ce:indexed-name": "Cheewatanakornkool K."
            },
            "@seq": "4",
            "ce:initials": "K.",
            "@_fa": "true",
            "affiliation": {
                "@id": "126193115",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126193115"
            },
            "ce:surname": "Cheewatanakornkool",
            "@auid": "23567587500",
            "author-url": "https://api.elsevier.com/content/author/author_id/23567587500",
            "ce:indexed-name": "Cheewatanakornkool K."
        },
        {
            "ce:given-name": "Siriwan",
            "preferred-name": {
                "ce:given-name": "Siriwan",
                "ce:initials": "S.",
                "ce:surname": "Nantaphol",
                "ce:indexed-name": "Nantaphol S."
            },
            "@seq": "5",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "126193115",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126193115"
            },
            "ce:surname": "Nantaphol",
            "@auid": "56091887200",
            "author-url": "https://api.elsevier.com/content/author/author_id/56091887200",
            "ce:indexed-name": "Nantaphol S."
        },
        {
            "ce:given-name": "Pornchai",
            "preferred-name": {
                "ce:given-name": "Pornchai",
                "ce:initials": "P.",
                "ce:surname": "Rojsitthisak",
                "ce:indexed-name": "Rojsitthisak P."
            },
            "@seq": "6",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                },
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                }
            ],
            "ce:surname": "Rojsitthisak",
            "@auid": "23989729000",
            "author-url": "https://api.elsevier.com/content/author/author_id/23989729000",
            "ce:indexed-name": "Rojsitthisak P."
        }
    ]}
}}